N+1 Singer shares its H1 2018 Review

In our H1 review, we discuss the UK economic and equity market environment and notable transactions completed in the first half of 2018.

[Video] Merck Mercuriadis, CEO & Founder of Hipgnosis Songs Fund Ltd.

Merck Mercuriadis, CEO & Founder of Hipgnosis Songs Fund Ltd. discusses the reasons for starting Hipgnosis, how changes in music consumption is driving growth, and what assets the fund will acquire.     

Read More
N+1 Singer Ranked as a Top 3 Adviser & Broker in the Latest Corporate Rankings Guide

N+1 Singer has been ranked as one of the top 3 firms by number of AIM clients, as both Financial Adviser and Stockbroker, in the latest Corporate Advisers Rankings Guide. Published quarterly, the Corporate Advisers Rankings

Read More
N+1 Singer appointed as NOMAD & Broker to Surgical Innovations Group Plc

Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, has today announced the appointment of N+1 Singer as Nominated Adviser and sole Broker to the Company with immediate effect. Ticker: SUN

Read More

Transaction Highlights

AVI Japan Opportunity Trust Plc

Date: October 2018

Sector: Investment Funds

Type: IPO


£80.0 million

Summerway Capital Plc

Date: October 2018

Sector: Consumer

Type: IPO


£5.73 million

Futura Medical Plc

Date: October 2018

Sector: Healthcare

Type: Placing, Subscription, Offer for Subscription and Planned Open Offer


£5.6 million

Communications about our events, transactions and industries.